In Brief: Pharmacia & Upjohn
This article was originally published in The Tan Sheet
Pharmacia & Upjohn: AB Volvo announces June 25 its plans to offer 46 mil. shares of Pharmacia & Upjohn stock -- about two-thirds of Volvo's stake in the company -- valued at almost $2 bil. Underwriters will have the option to purchase an additional 6.9 mil. shares to cover possible over-allotments. Volvo expects to price the stock offering by the week of July 22. To protect its interest in divesting its stake in Pharmacia & Upjohn, Volvo apparently blocked the company's efforts to acquire Allergan in May ("The Tan Sheet" May 20, In Brief)...
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC